尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Yerxa Benjamin R. Officer active across 2 companies, notably Clearside Biomedical, Inc.. In total, 7 filings have been published. Split: 2 buys · 2 sells. Total volume traded: €72k. History available since 15 May 2024. The latest transaction was disclosed on 23 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
YERXA BENJAMIN R is a declarant linked to Opus Genetics, Inc. and Clearside Biomedical, Inc. The 4 filings tracked cover the period from 2024-05-15 to 2026-04-27, with buys of EUR 18723 and sells of EUR 33483 in this recent sample. The modal transaction nature is Acquisition.